Skip to main content
. 2015 Nov 20;94(46):e2014. doi: 10.1097/MD.0000000000002014

FIGURE 2.

FIGURE 2

Estimated odds ratio of risk for skeletal-related events for patients with breast cancer under bisphosphonates therapy.